Terms: = Skin cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5
588 results:
1. Pachydysostosis of the fibula in a case of familial adenomatous polyposis.
Oliveira D; Maia S; Balacó I; Coelho P; Almeida S; Venâncio M; Saraiva J; Nishimura G; Sousa SB
Eur J Med Genet; 2024 Apr; 68():104913. PubMed ID: 38286305
[TBL] [Abstract] [Full Text] [Related]
2. Thirty-two-year trends of cancer incidence by sex and cancer site in the Veneto Region from 1987 to 2019.
Buja A; De Luca G; Zorzi M; Bovo E; Mocellin S; Trevisiol C; Bronte V; Guzzinati S; Rugge M
Front Public Health; 2023; 11():1267534. PubMed ID: 38259775
[TBL] [Abstract] [Full Text] [Related]
3. A novel molecular subtyping based on multi-omics analysis for prognosis predicting in colorectal melanoma: A 16-year prospective multicentric study.
Liu C; Cheng X; Han K; Hong L; Hao S; Sun X; Xu J; Li B; Jin D; Tian W; Jin Y; Wang Y; Fang W; Bao X; Zhao P; Chen D
Cancer Lett; 2024 Mar; 585():216663. PubMed ID: 38246221
[TBL] [Abstract] [Full Text] [Related]
4. Global, Regional, and National Incidence Trend Analysis of Malignant skin Melanoma Between 1990 and 2019, and Projections Until 2034.
Yuan J; Li X; Yu S
Cancer Control; 2024; 31():10732748241227340. PubMed ID: 38227397
[TBL] [Abstract] [Full Text] [Related]
5. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
6. Melanocytic Neoplasm With KIT and apc Mutations: A New Subtype of Melanocytoma?
Donati M; Grossmann P; Mansour B; Kazakov DV
Am J Dermatopathol; 2024 Feb; 46(2):107-110. PubMed ID: 37982490
[TBL] [Abstract] [Full Text] [Related]
7. Epidermal growth factor receptor inhibitors in advanced cutaneous squamous cell carcinoma: A systematic review and meta-analysis.
Pham JP; Rodrigues A; Goldinger SM; Sim HW; Liu J
Exp Dermatol; 2024 Jan; 33(1):e14978. PubMed ID: 37971204
[TBL] [Abstract] [Full Text] [Related]
8. Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens.
Karimpour M; Totonchi M; Behmanesh M; Montazeri H
Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37863651
[TBL] [Abstract] [Full Text] [Related]
9. Comparative age-period-cohort analysis.
Rosenberg PS; Miranda-Filho A; Whiteman DC
BMC Med Res Methodol; 2023 Oct; 23(1):238. PubMed ID: 37853346
[TBL] [Abstract] [Full Text] [Related]
10. Cost-utility analysis of Pembrolizumab compared to other alternative immunotherapy and chemotherapy treatments for patients with advanced melanoma in Iran.
Bashari N; Safaei Lari M; Darvishi A; Daroudi R
Expert Rev Pharmacoecon Outcomes Res; 2024 Feb; 24(2):273-284. PubMed ID: 37750606
[TBL] [Abstract] [Full Text] [Related]
11. Telomere length is associated with increased risk of cutaneous melanoma: a Mendelian randomization study.
Liu M; Lan Y; Zhang H; Zhang X; Wu M; Yang L; Zhou J; Tong M; Leng L; Zheng H; Li J; Mi X
Melanoma Res; 2023 Dec; 33(6):475-481. PubMed ID: 37650705
[TBL] [Abstract] [Full Text] [Related]
12. Dermatofibroma Versus Dermatofibrosarcoma Protuberans: A Nuclear Morphology Study.
Khamdan F; Brailsford C; Dirr MA; Sagut P; Nietert PJ; Elston D
Am J Dermatopathol; 2023 Sep; 45(9):631-634. PubMed ID: 37625803
[TBL] [Abstract] [Full Text] [Related]
13. Open Versus Core Needle Biopsy in Lower-Extremity Sarcoma: Current Practice Patterns and Patient Outcomes.
Burke ZDC; Lazarides AL; Gundavda MK; Griffin AM; Tsoi KM; Ferguson PC; Wunder JS;
J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):57-64. PubMed ID: 37466581
[TBL] [Abstract] [Full Text] [Related]
14. Counts, incidence rates, and trends of pediatric cancer in the United States, 2003-2019.
Siegel DA; King JB; Lupo PJ; Durbin EB; Tai E; Mills K; Van Dyne E; Buchanan Lunsford N; Henley SJ; Wilson RJ
J Natl Cancer Inst; 2023 Nov; 115(11):1337-1354. PubMed ID: 37433078
[TBL] [Abstract] [Full Text] [Related]
15. Current Patterns of Treatment and Outcomes in Advanced Melanoma at a Single Institution.
Rose MA; Miura J; Sharon C; Ermer JP; Karakousis G; Wachtel H
J Surg Res; 2023 Nov; 291():25-33. PubMed ID: 37331189
[TBL] [Abstract] [Full Text] [Related]
16. HLA-B27 positivity in a large miscegenated population of 5,389,143 healthy blood marrow donors in Brazil.
Resende GG; Saad CGS; de Oliveira DCM; de Sousa Bueno Filho JS; Sampaio-Barros PD; de Medeiros Pinheiro M
Adv Rheumatol; 2023 Apr; 63(1):16. PubMed ID: 37081582
[TBL] [Abstract] [Full Text] [Related]
17. Comparison of statistical models to predict age-standardized cancer incidence in Switzerland.
Trächsel B; Rousson V; Bulliard JL; Locatelli I
Biom J; 2023 Oct; 65(7):e2200046. PubMed ID: 37078835
[TBL] [Abstract] [Full Text] [Related]
18. Time trends and survival of marginal zone lymphoma over 25 years in Girona, Spain (1994-2018).
Auñón C; Sanvisens A; Turon E; Vidal-Vila A; Puigdemont M; Osca-Gelis G; Eraso A; Marcos-Gragera R
Cancer Med; 2023 Jun; 12(11):12343-12353. PubMed ID: 37076996
[TBL] [Abstract] [Full Text] [Related]
19. Incidence and survival of patients with primary gastrointestinal melanoma: a population-based study.
Du Y; Chang X; Li X; Xing S
Int J Colorectal Dis; 2023 Mar; 38(1):87. PubMed ID: 36991139
[TBL] [Abstract] [Full Text] [Related]
20. Analysis of the Mortality Trends of 23 Major cancers in the Indian Population Between 2000 and 2019: A Joinpoint Regression Analysis.
Shaji A; Keechilat P; Dk V; Sauvaget C
JCO Glob Oncol; 2023 Mar; 9():e2200405. PubMed ID: 36947728
[TBL] [Abstract] [Full Text] [Related]
[Next]